CoChat

Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors

Open access
Jacob, Tija C. · 2019 · Frontiers in Molecular Neuroscience
Cited by 122

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

α5 subunit containing GABA type A receptors (GABAARs) have long been an enigmatic receptor subtype of interest due to their specific brain distribution, unusual surface localization and key role in synaptic plasticity, cognition and memory. These receptors are uniquely positioned to sculpt both the developing and mature hippocampal circuitry due to high overall expression and a distinct peak during the critical synapse formation period during the second postnatal week. Unlike the majority of other GABAARs, they exhibit both receptor clustering at extrasynaptic sites via interactions with the radixin scaffold as well as synaptic sites via gephyrin, thus contributing respectively to tonic currents and synaptic GABAergic neurotransmission. α5 GABAAR signaling can be altered in neurodevelopmental disorders including autism and mental retardation and by inflammation in CNS injury and disease. Due to the unique physiology and pharmacology of α5 GABAARs, drugs targeting these receptors are being developed and tested as treatments for neurodevelopmental disorders, depression, schizophrenia, and mild cognitive impairment. This review focuses on advances in understanding how the α5 subunit contributes to GABAAR neurobiology. In particular I discuss both recent insights and remaining knowledge gaps for the functional role of these receptors, pathologies associated with α5 GABAAR dysfunction, and the effects and potential therapeutic uses of α5 receptor subtype targeted drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnmol.2019.00179

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 87

  1. Ambrad Giovannetti, 2019, Unsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease, Brain Res., 1707, 216, 10.1016/j.brainres.2018.11.042 · DOI · Paper page
  2. Araujo, 1999, Native γ-aminobutyric acid type A receptors from rat hippocampus, containing both α 1 and α 5 subunits, exhibit a single benzodiazepine binding site with α 5 pharmacological properties, J. Pharmacol. Exp. Ther., 290, 989
  3. Atack, 2010, Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA, Pharmacol. Ther., 125, 11, 10.1016/j.pharmthera.2009.09.001 · DOI
  4. Atack, 2011, GABAA receptor subtype-selective modulators: II. α5-selective inverse agonists for cognition enhancement, Curr. Top. Med. Chem., 11, 1203, 10.2174/156802611795371314 · DOI
  5. Atack, 2006, L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors, Neuropharmacology, 51, 1023, 10.1016/j.neuropharm.2006.04.018 · DOI · Paper page
  6. Atack, 2009, In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)- pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor α5 subtype-selective inverse agonist, J. Pharmacol. Exp. Ther., 331, 470, 10.1124/jpet.109.157636 · DOI
  7. Bader, 2017, Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings, PLoS One, 12, e0186147, 10.1371/journal.pone.0186147 · DOI
  8. Bakker, 2003, Understanding fragile X syndrome: insights from animal models, Cytogenet. Genome Res., 100, 111, 10.1159/000072845 · DOI
  9. Balic, 2009, The α5(H105R) mutation impairs α5 selective binding properties by altered positioning of the α5 subunit in GABAA receptors containing two distinct types of α subunits, J. Neurochem., 110, 244, 10.1111/j.1471-4159.2009.06119.x · DOI
  10. Ballard, 2009, RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors, Psychopharmacology, 202, 207, 10.1007/s00213-008-1357-7 · DOI
  11. Ben-Ari, 2007, GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations, Physiol. Rev., 87, 1215, 10.1152/physrev.00017.2006 · DOI · Paper page
  12. Bonin, 2007, α5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons, J. Neurophysiol., 98, 2244, 10.1152/jn.00482.2007 · DOI
  13. Brady, 2015, Synaptic localization of α5 GABAA receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation, Dev. Neurobiol., 75, 1241, 10.1002/dneu.22280 · DOI
  14. Braudeau, 2011, Chronic treatment with a promnesiant GABA-A α5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a down syndrome mouse model, Adv. Pharmacol. Sci., 2011, 153218, 10.1155/2011/153218 · DOI · Paper page
  15. Brünig, 2002, Intact sorting, targeting, and clustering of γ-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro, J. Comp. Neurol., 443, 43, 10.1002/cne.10102 · DOI · Paper page
  16. Butler, 2018, De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy, Brain, 141, 2392, 10.1093/brain/awy171 · DOI · Paper page
  17. Caraiscos, 2004, Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors, Proc. Natl. Acad. Sci. U S A, 101, 3662, 10.1073/pnas.0307231101 · DOI · Paper page
  18. Chambers, 2002, 6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A α5 receptor inverse agonists, J. Med. Chem., 45, 1176, 10.1021/jm010471b · doi:10.1021/jm010471b
  19. Chambers, 2003, Identification of a novel, selective GABAA α5 receptor inverse agonist which enhances cognition, J. Med. Chem., 46, 2227, 10.1021/jm020582q · DOI
  20. Chen, 2017, Physiological and pharmacological properties of inhibitory postsynaptic currents mediated by α5β1γ2, α5β2γ2 and α5β3γ2 GABAA receptors, Neuropharmacology, 125, 243, 10.1016/j.neuropharm.2017.07.027 · DOI
  21. Cheng, 2006, α5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate, J. Neurosci., 26, 3713, 10.1523/JNEUROSCI.5024-05.2006 · DOI · Paper page
  22. Christie, 2002, α5 subunit-containing GABAA receptors form clusters at GABAergic synapses in hippocampal cultures, Neuroreport, 13, 2355, 10.1097/00001756-200212030-00037 · DOI
  23. Clayton, 2015, A review of the updated pharmacophore for the α 5 GABAA benzodiazepine receptor model, Int. J. Med. Chem., 2015, 430248, 10.1155/2015/430248 · DOI
  24. Crestani, 2002, Trace fear conditioning involves hippocampal α5 GABAA receptors, Proc. Natl. Acad. Sci. U S A, 99, 8980, 10.1073/pnas.142288699 · DOI · Paper page
  25. Curia, 2009, Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome, Cereb. Cortex, 19, 1515, 10.1093/cercor/bhn159 · DOI · Paper page
  26. Deidda, 2015, Reversing excitatory GABAA signaling restores synaptic plasticity and memory in a mouse model of Down syndrome, Nat. Med., 21, 318, 10.1038/nm.3827 · DOI · Paper page
  27. del Río, 2001, Prevalence between different α subunits performing the benzodiazepine binding sites in native heterologous GABAA receptors containing the α2 subunit, J. Neurochem., 79, 183, 10.1046/j.1471-4159.2001.00551.x · DOI
  28. Deprez, 2016, Partial inactivation of GABAA receptors containing the α5 subunit affects the development of adult-born dentate gyrus granule cells, Eur. J. Neurosci., 44, 2258, 10.1111/ejn.13329 · DOI
  29. Etherington, 2017, Selective inhibition of extra-synaptic α5-GABAA receptors by S44819, a new therapeutic agent, Neuropharmacology, 125, 353, 10.1016/j.neuropharm.2017.08.012 · DOI
  30. Ge, 2006, GABA regulates synaptic integration of newly generated neurons in the adult brain, Nature, 439, 589, 10.1038/nature04404 · DOI · Paper page
  31. Gill, 2011, A novel α5GABAAR-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia, Neuropsychopharmacology, 36, 1903, 10.1038/npp.2011.76 · DOI · Paper page
  32. Giusi, 2009, Distinct α subunits of the GABAA receptor are responsible for early hippocampal silent neuron-related activities, Hippocampus, 19, 1103, 10.1002/hipo.20584 · DOI
  33. Glykys, 2006, Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABAA receptor α5 subunit-deficient mice, J. Neurophysiol., 95, 2796, 10.1152/jn.01122.2005 · DOI · Paper page
  34. Hauser, 2005, Hippocampal α5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition, Mol. Psychiatry, 10, 201, 10.1038/sj.mp.4001554 · DOI
  35. Herd, 2008, The expression of GABAAβ subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells, J. Physiol., 586, 989, 10.1113/jphysiol.2007.146746 · DOI
  36. Hernandez, 2016, Deleterious rare variants reveal risk for loss of GABAA receptor function in patients with genetic epilepsy and in the general population, PLoS One, 11, e0162883, 10.1371/journal.pone.0162883 · DOI
  37. Hogart, 2010, The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13, Neurobiol. Dis., 38, 181, 10.1016/j.nbd.2008.08.011 · DOI · Paper page
  38. Hu, 2018, Cell type-specific gene expression of α 5 subunit-containing γ-aminobutyric acid subtype A receptors in human and mouse frontal cortex, Mol. Neuropsychiatry, 4, 204, 10.1159/000495840 · DOI
  39. Ju, 2009, Distinct properties of murine α5 γ-aminobutyric acid type a receptors revealed by biochemical fractionation and mass spectroscopy, J. Neurosci. Res., 87, 1737, 10.1002/jnr.21991 · DOI
  40. Kazdoba, 2016, Translational mouse models of autism: advancing toward pharmacological therapeutics, Curr. Top. Behav. Neurosci., 28, 1, 10.1007/7854_2015_5003 · DOI · Paper page
  41. Koh, 2013, Selective GABAA α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment, Neuropharmacology, 64, 145, 10.1016/j.neuropharm.2012.06.023 · DOI
  42. Laverty, 2019, Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer, Nature, 565, 516, 10.1038/s41586-018-0833-4 · DOI · Paper page
  43. Lecker, 2013, Potentiation of GABAA receptor activity by volatile anaesthetics is reduced by α5GABAA receptor-preferring inverse agonists, Br. J. Anaesth., 110, i73, 10.1093/bja/aet038 · DOI
  44. Lévi, 2015, Benzodiazepine ligands rapidly influence GABAA receptor diffusion and clustering at hippocampal inhibitory synapses, Neuropharmacology, 88, 199, 10.1016/j.neuropharm.2014.06.002 · DOI
  45. Ling, 2015, A novel GABAA α 5 receptor inhibitor with therapeutic potential, Eur. J. Pharmacol., 764, 497, 10.1016/j.ejphar.2015.07.005 · DOI
  46. Lisman, 2008, A neural coding scheme formed by the combined function of gamma and theta oscillations, Schizophr. Bull., 34, 974, 10.1093/schbul/sbn060 · DOI · Paper page
  47. Lissemore, 2018, Reduced GABAergic cortical inhibition in aging and depression, Neuropsychopharmacology, 43, 2277, 10.1038/s41386-018-0093-x · DOI
  48. Liu, 1998, The α5 subunit of the murine type A GABA receptor, Mol. Brain Res., 59, 84, 10.1016/s0169-328x(98)00144-2 · doi:10.1016/s0169-328x(98)00144-2
  49. Loebrich, 2006, Activated radixin is essential for GABAA receptor α5 subunit anchoring at the actin cytoskeleton, EMBO J., 25, 987, 10.1038/sj.emboj.7600995 · DOI · Paper page
  50. Lorenz-Guertin, 2019, Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking, Cell. Neurosci., 13, 163, 10.3389/fncel.2019.00163 · DOI
  51. Lucas-Osma, 2018, Extrasynaptic α5GABAA receptors on proprioceptive afferents produce a tonic depolarization that modulates sodium channel function in the rat spinal cord, J. Neurophysiol., 120, 2953, 10.1152/jn.00499.2018 · DOI
  52. Magnin, 2019, Input-specific synaptic location and function of the α5 GABAA receptor subunit in the mouse CA1 hippocampal neurons, J. Neurosci., 39, 788, 10.1523/JNEUROSCI.0567-18.2018 · DOI · Paper page
  53. Marchionni, 2007, In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells, J. Physiol., 581, 515, 10.1113/jphysiol.2006.125609 · DOI
  54. Martin, The physiological properties and therapeutic potential of α5-GABAA receptors, Biochem. Soc. Trans., 37, 1334, 10.1042/BST0371334 · DOI
  55. Martin, Etomidate targets α5 γ-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade, Anesthesiology, 111, 1025, 10.1097/ALN.0b013e3181bbc961 · DOI · Paper page
  56. Martin, 2010, α5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory, J. Neurosci., 30, 5269, 10.1523/JNEUROSCI.4209-09.2010 · DOI · Paper page
  57. Martínez-Cué, 2013, Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome, J. Neurosci., 33, 3953, 10.1523/JNEUROSCI.1203-12.2013 · DOI · Paper page
  58. Masiulis, 2019, GABAA receptor signalling mechanisms revealed by structural pharmacology, Nature, 565, 454, 10.1038/s41586-018-0832-5 · DOI · Paper page
  59. Mendez, 2013, The brain GABA-benzodiazepine receptor α-5 subtype in autism spectrum disorder: a pilot [11C]Ro15–4513 positron emission tomography study, Neuropharmacology, 68, 195, 10.1016/j.neuropharm.2012.04.008 · DOI
  60. Mesbah-Oskui, 2017, Reduced expression of α5GABAA receptors elicits autism-like alterations in EEG patterns and sleep-wake behavior, Neurotoxicol. Teratol., 61, 115, 10.1016/j.ntt.2016.10.009 · DOI
  61. Olsen, 2009, GABAA receptors: subtypes provide diversity of function and pharmacology, Neuropharmacology, 56, 141, 10.1016/j.neuropharm.2008.07.045 · DOI · Paper page
  62. Pangratz-Fuehrer, 2016, Early postnatal switch in GABAA receptor α-subunits in the reticular thalamic nucleus, J. Neurophysiol., 115, 1183, 10.1152/jn.00905.2015 · DOI
  63. Perez-Sanchez, 2017, α5GABAA receptors mediate tonic inhibition in the spinal cord dorsal horn and contribute to the resolution of hyperalgesia, J. Neurosci. Res., 95, 1307, 10.1002/jnr.23981 · DOI
  64. Phulera, 2018, Cryo-EM structure of the benzodiazepine-sensitive α1β1γ2S tri-heteromeric GABAA receptor in complex with GABA, eLife, 7, e39383, 10.7554/elife.39383 · DOI · Paper page
  65. Piantadosi, 2016, Sex-dependent anti-stress effect of an α5 subunit containing GABAA receptor positive allosteric modulator, Front. Pharmacol., 7, 446, 10.3389/fphar.2016.00446 · DOI · Paper page
  66. Prenosil, 2006, Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons, J. Neurophysiol., 96, 846, 10.1152/jn.01199.2006 · doi:10.1152/jn.01199.2006 · Paper page
  67. Prevot, 2019, Novel benzodiazepine-like ligands with various anxiolytic, antidepressant, or pro-cognitive profiles, Mol. Neuropsychiatry, 5, 84, 10.1159/000496086 · DOI · Paper page
  68. Ramos, 2004, Expression of α 5 GABAA receptor subunit in developing rat hippocampus, Dev. Brain Res., 151, 87, 10.1111/j.0953-816x.2004.03349.x · DOI · Paper page
  69. Renner, 2012, Diffusion barriers constrain receptors at synapses, PLoS One, 7, e43032, 10.1371/journal.pone.0043032 · DOI
  70. Rozycka, 2017, The space where aging acts: focus on the GABAergic synapse, Aging Cell, 16, 634, 10.1111/acel.12605 · DOI · Paper page
  71. Saab, 2010, Short-term memory impairment after isoflurane in mice is prevented by the α5 γ-aminobutyric acid type A receptor inverse agonist L-655,708, Anesthesiology, 113, 1061, 10.1097/ALN.0b013e3181f56228 · DOI
  72. Schulz, 2018, Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear α5-GABAA receptors, Nat. Commun., 9, 3576, 10.1038/s41467-018-06004-8 · DOI
  73. Schulz, 2019, Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of down syndrome, J. Neurosci., 39, 5210, 10.1523/JNEUROSCI.2723-18.2019 · DOI
  74. Serwanski, 2006, Synaptic and nonsynaptic localization of GABAA receptors containing the α5 subunit in the rat brain, J. Comp. Neurol., 499, 458, 10.1002/cne.21115 · DOI · Paper page
  75. Sieghart, 2018, International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans, Pharmacol. Rev., 70, 836, 10.1124/pr.117.014449 · DOI · Paper page
  76. Street, 2004, Synthesis and biological evaluation of 3-Heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABAAα5 benzodiazepine binding site, J. Med. Chem., 47, 3642, 10.1021/jm0407613 · DOI
  77. Sur, 1999, Autoradiographic localization of α5 subunit-containing GABAA receptors in rat brain, Brain Res., 822, 265, 10.1016/s0006-8993(99)01152-x · DOI
  78. Sur, 1998, Rat and human hippocampal α5 subunit-containing γ-aminobutyric AcidA receptors have α5 β3 γ2 pharmacological characteristics, Mol. Pharmacol., 54, 928, 10.1124/mol.54.5.928 · DOI
  79. Towers, 2004, α 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced γ frequency oscillations in vitro, J. Physiol., 559, 721, 10.1113/jphysiol.2004.071191 · DOI
  80. Vargas-Caballero, 2010, α5 Subunit-containing GABAA receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation, Neuropharmacology, 58, 668, 10.1016/j.neuropharm.2009.11.005 · DOI
  81. Vidal, 2018, Decreasing the expression of GABAA α5 subunit-containing receptors partially improves cognitive, electrophysiological, and morphological hippocampal defects in the Ts65Dn model of down syndrome, Mol. Neurobiol., 55, 4745, 10.1007/s12035-017-0675-3 · DOI
  82. Wang, 2012, Memory deficits induced by inflammation are regulated by α5-subunit-containing GABAA receptors, Cell Rep., 2, 488, 10.1016/j.celrep.2012.08.022 · DOI · Paper page
  83. Zarnowska, 2009, GABAA receptor α5 subunits contribute to GABAA,slow synaptic inhibition in mouse hippocampus, J. Neurophysiol., 101, 1179, 10.1152/jn.91203.2008 · DOI · Paper page
  84. Zhao, 2019, Inhibition of α5 GABAA receptors has preventive but not therapeutic effects on isoflurane-induced memory impairment in aged rats, Neural Regen. Res., 14, 1029, 10.4103/1673-5374.250621 · DOI
  85. Zhu, 2018, Structure of a human synaptic GABAA receptor, Nature, 559, 67, 10.1038/s41586-018-0255-3 · DOI · Paper page
  86. Zurek, 2016, α5GABAA receptor deficiency causes autism-like behaviors, Ann. Clin. Transl. Neurol., 3, 392, 10.1002/acn3.303 · DOI
  87. Zurek, 2014, Sustained increase in α5GABAA receptor function impairs memory after anesthesia, J. Clin. Invest., 124, 5437, 10.1172/JCI76669 · DOI · Paper page

Cited by

See all 122

Metadata

Authors
Jacob, T. C.
Venue
Frontiers in Molecular Neuroscience
Published
2019-07-24
Volume
12
Pages
179-179
ISSN
1662-5099 (ISSN-L)
OpenAlex
W2960913096
Cited by
122
References
15
FWCI
6.17
Type
journal article
Language
en
Open access
gold
Funders
National Institute of Mental Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors. https://app.cochat.ai/papers/10.3389/fnmol.2019.00179
The paper
Jacob, T. C. (2019). Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors. Frontiers in Molecular Neuroscience. https://doi.org/10.3389/fnmol.2019.00179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.